Back to search
FDAFDA · Food and drugs·Recall number D-0479-2026

Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172, NDC 69374-330-05.

Published April 22, 2026 · Recall initiated: March 17, 2026

Summary

FDA records drug Class II recall D-0479-2026, published April 22, 2026 and initiated March 17, 2026. Recalling firm: Nephron SC, LLC; Status: Ongoing; Reported quantity: 146,280 vials; Lot: Lot AB6001, exp date 1/15/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labelling: Illegible label

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron SC, LLC
Distributor
Nationwide within the United States
Lot
Lot AB6001, exp date 1/15/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172, NDC 69374-330-05. recalled?

Yes. FDA published recall D-0479-2026 on April 22, 2026. Reported hazard: Labelling: Illegible label

What should I do if I have this product?

Voluntary: Firm initiated